31 Dec 2016 Date | | - Cons. EPS | 0 EPS |
30 Sep 2016 Date | | - Cons. EPS | - EPS |
30 Jun 2016 Date | | - Cons. EPS | - EPS |
31 Mar 2016 Date | | - Cons. EPS | - EPS |
31 Dec 2015 Date | | - Cons. EPS | - EPS |
31 Dec 2016 Date | | - Cons. EPS | 0 EPS |
30 Sep 2016 Date | | - Cons. EPS | - EPS |
30 Jun 2016 Date | | - Cons. EPS | - EPS |
31 Mar 2016 Date | | - Cons. EPS | - EPS |
31 Dec 2015 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Darren Cherry CEO | EXPM Exchange | US0076141003 ISIN |
US Country | 5 Employees | - Last Dividend | - Last Split | - IPO Date |
Advantis Corp., originally known as Ramoil Management, Ltd., is a company that operates within the medical cannabis, research, and pharmaceutical sectors. With a strategic focus on developing and marketing a variety of products aimed at pain management and healthcare solutions, Advantis Corp. made a significant rebranding move by changing its name from Ramoil Management, Ltd. to Advantis Corp. in December 2015. The company is headquartered in Newport Beach, California, positioning itself as a key player in the evolving market of medical cannabis and healthcare services.
Advantis Corp. develops and markets a range of products tailored for the medical cannabis sector. These products are designed to meet the needs of patients requiring medical cannabis for therapeutic purposes, focusing on pain relief, and management. By tapping into the medicinal benefits of cannabis, Advantis offers alternatives to traditional pain medication.
Apart from its focus on medical cannabis, Advantis Corp. is also actively involved in research and pharmaceutical services. The company collaborates with other entities and invests in research projects aimed at exploring new treatments and healthcare solutions, thereby contributing to scientific advances in medicine.
Recognizing the critical need for effective pain management solutions, Advantis Corp. offers a portfolio of products and services dedicated to addressing various pain conditions. These solutions are part of the company's commitment to improving the quality of life for individuals suffering from chronic pain and other pain-related issues.